	Spese Di Vendita E Di Amministrazione		Data
AbbVie	USD 3.89B	325M	2025-12
Acadia Pharmaceuticals	USD 124.9M	1.24M	2025-09
Akebia Therapeutics	USD 25.74M	1.93M	2025-03
ALKERMES	USD 171.77M	17.9M	2025-09
Alnylam Pharmaceuticals	USD 262.59M	60.72M	2025-09
Amarin	USD 17.94M	17.86M	2025-09
Amgen	USD 1.94B	237M	2025-12
Baxter International	USD 708M	10M	2025-09
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Coherus Biosciences	USD 26.02M	8.57M	2025-03
Eli Lilly	USD 3.13B	391.3M	2025-12
Fujifilm	JPY 215.83B	2.93B	2025-12
Gilead Sciences	USD 1.35B	6M	2025-09
Ironwood Pharmaceuticals	USD 33.33M	2.78M	2024-12
Merck	USD 2.85B	215M	2025-12
Myriad Genetics	USD 129M	1.3M	2025-09
Pacira	USD 91.8M	14.6M	2025-09
Perrigo	USD 245.7M	27.4M	2025-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 84.05M	1.22M	2025-09
Regeneron Pharmaceuticals	USD 775M	117.2M	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Teva Pharmaceutical Industries	USD 1.12B	147M	2025-12
Vertex Pharmaceuticals	USD 445.1M	20.5M	2025-09
Xencor	USD 87.78M	72.66M	2025-09
Zoetis	USD 579M	29M	2025-09

Coherus Biosciences Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.